IFNG and autoimmune thrombocytopenic purpura: Regards the association between these genes and clinical characteristics, treatment and response to treatment in cases, we demonstrated that significant higher IFNG-AS1 and GAS5 (p < 0.05) were present in persistent ITP (3–12 months) [ median (IQR) = 4.58 (0.31–22.39) for IFNG-AS1 and 3.77 (0.87–12.36) for GAS5] or chronic ITP (>12 months) [ median (IQR) = 5.6 (0.25–12.59) for IFNG-AS1 and 5.61 (1.15–16.91) for GAS5] when compared to newly diagnosed <3 months patients [IFNG-AS1 median (IQR) = 1.21 (0.2–8.95), and GAS5 median (IQR) = 1.07 (0.09–3.55)].